WILHELMUS CM GROENHUYSEN - 01 Mar 2024 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Operating Officer
Signature: Steven Robbins, as attorney in fact for Groenhuysen, Wilhelmus CM
Issuer symbol: NVCR
Transactions as of: 01 Mar 2024
Net transactions value: -$53,253
Form type: 4
Filing time: 05 Mar 2024, 16:09:41 UTC
Previous filing: 29 Feb 2024
Next filing: 07 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Sale	$33,769	-2,107	-0.83%	$16.03	252,452	01 Mar 2024	Direct	F1
transaction	NVCR	Ordinary Shares	Sale	$19,484	-1,217	-0.48%	$16.01	251,235	04 Mar 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.